Abstract
Epstein-Barr virus (EBV) is a B-lymphotropic virus that is associated with a range of human malignancies. Although for many of these tumors the association has long been established, unraveling the precise role of EBV in disease pathogenesis has been more difficult. This review summarizes current knowledge concerning the association between EBV and human cancers, and illustrates how a deeper insight into viral latent gene expression, regulation and functions in different cell environments is already helping towards a better understanding of both the natural history of infection in normal individuals and how EBV contributes to malignant transformation. Finally, therapeutic strategies targeting EBV in tumors are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 2672-2713 |
| Number of pages | 42 |
| Journal | Frontiers in bioscience : a journal and virtual library |
| Volume | 11 |
| Issue number | SUPPL. 2 |
| DOIs | |
| Publication status | Published - 2006 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Apoptosis
- Carcinoma
- CpG
- EBV
- Epstein-Barr virus
- Herpesvirus
- Immortalization
- Immunosuppression
- Latent
- Lymphoma
- Lytic
- Methylation
- Nasopharyngeal
- Persistence
- Promoter
- Review
- Therapy
- Transformation
Fingerprint
Dive into the research topics of 'Epstein-Barr virus (EBV) and its associated human cancers - Genetics, epigenetics, pathobiology and novel therapeutics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver